Bank of New York Mellon’s Champions Oncology CSBR Stock Holding History

Bank of New York Mellon’s Portfolio CSBR Stock Details CSBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$133K	Hold	21,614	–	–	﹤0.01%	4181
2026 Q1	$124K	Sell	21,614 -5,135	-19%	-$32.6K	﹤0.01%	4077
2025 Q4	$185K	Hold	26,749	–	–	﹤0.01%	4046
2025 Q3	$173K	Hold	26,749	–	–	﹤0.01%	4049
2025 Q2	$197K	Hold	26,749	–	–	﹤0.01%	3992
2025 Q1	$232K	Hold	26,749	–	–	﹤0.01%	3822
2024 Q4	$229K	Hold	26,749	–	–	﹤0.01%	3902
2024 Q3	$130K	Hold	26,749	–	–	﹤0.01%	3980
2024 Q2	$138K	Hold	26,749	–	–	﹤0.01%	3999
2024 Q1	$131K	Sell	26,749 -4,026	-13%	-$23.6K	﹤0.01%	4004
2023 Q4	$173K	Hold	30,775	–	–	﹤0.01%	3990
2023 Q3	$191K	Hold	30,775	–	–	﹤0.01%	3968
2023 Q2	$196K	Hold	30,775	–	–	﹤0.01%	3978
2023 Q1	$124K	Hold	30,775	–	–	﹤0.01%	4040
2022 Q4	$139K	Hold	30,775	–	–	﹤0.01%	4071
2022 Q3	$231K	Hold	30,775	–	–	﹤0.01%	3955
2022 Q2	$246K	Hold	30,775	–	–	﹤0.01%	3975
2022 Q1	$250K	Hold	30,775	–	–	﹤0.01%	4117
2021 Q4	$257K	Hold	30,775	–	–	﹤0.01%	4158
2021 Q3	$314K	Sell	30,775 -21,050	-41%	-$214K	﹤0.01%	4017
2021 Q2	$533K	Sell	51,825 -16,424	-24%	-$167K	﹤0.01%	3740
2021 Q1	$772K	Sell	68,249 -490	-0.7%	-$5.69K	﹤0.01%	3475
2020 Q4	$741K	Sell	68,739 -754	-1%	-$7.78K	﹤0.01%	3420
2020 Q3	$642K	Hold	69,493	–	–	﹤0.01%	3366
2020 Q2	$664K	Buy	69,493 +17,178	+33%	+$146K	﹤0.01%	3325
2020 Q1	$387K	Hold	52,315	–	–	﹤0.01%	3492
2019 Q4	$436K	Hold	52,315	–	–	﹤0.01%	3651
2019 Q3	$295K	Hold	52,315	–	–	﹤0.01%	3782
2019 Q2	$409K	Hold	52,315	–	–	﹤0.01%	3696
2019 Q1	$512K	Sell	52,315 -164	-0.3%	-$1.63K	﹤0.01%	3538
2018 Q4	$409K	Buy	+52,479	New	+$603K	﹤0.01%	3586

Other funds holding CSBR

TAM

Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MFIM

Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

CCWM

Cassaday & Co Wealth Management Mclean, Virginia $5.32B AUM 22.63% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Bank of New York Mellon's CSBR Position: Q2 2026 in Review

Bank of New York Mellon held its Champions Oncology (CSBR) position steady in Q2 2026 at 21,614 shares worth $133K. The position accounts for ﹤0.01% of the portfolio, ranked #4181.

Bank of New York Mellon first reported a position in CSBR in Q4 2018 and has held it in 31 quarters since. The position peaked at $772K in Q1 2021. 10 funds tracked by Wall St. Rank hold CSBR as of Q2 2026.

Bank of New York Mellon held 21,614 shares of Champions Oncology worth $133K as of Q2 2026.
Bank of New York Mellon left its Champions Oncology share count unchanged in Q2 2026.
Champions Oncology made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #4181 holding.
Bank of New York Mellon first reported a position in Champions Oncology in Q4 2018 and has held it in 31 quarters since.
Bank of New York Mellon's Champions Oncology position peaked at $772K in Q1 2021.
10 funds tracked by Wall St. Rank held Champions Oncology as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.